Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Elsevier
Publish with us
Press release

Corporal punishment affects brain activity, anxiety, and depression

Philadelphia | November 16, 2022

Don’t spank your kids. That’s the conventional wisdom that has emerged from decades of research linking corporal punishment to a decline in adolescent health and negative effects on behavior, including an increased risk for anxiety and depression. Now, a new study(opens in new tab/window) explores how corporal punishment might impact neural systems to produce those adverse effects.

Corporal punishment can be simply defined as the “intentional infliction of physical pain by any means for the purpose of punishment, correction, discipline, instruction, or any other reason.” This violence, particularly when inflicted by a parent, evokes a complex emotional experience. The researchers, led by Kreshnik Burani, MS, and working with Greg Hajcak, PhD, at Florida State University, wanted to understand the neural underpinnings of that experience and its downstream consequences.

The study appears in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging(opens in new tab/window), published by Elsevier.

The researchers conducted a longitudinal study on 149 boys and girls ages 11 to 14 from the Tallahassee, FL, area. Participants performed a video game-like task and a monetary guessing game while undergoing continuously recorded electroencephalography, or EEG – a noninvasive technique to measure brain-wave activity from the scalp. From the EEG data, the researchers determined two scores for each participant – one reflecting their neural response to error and the other reflecting their neural response to reward.

Two years later, participants and their parents completed a series of questionnaires to screen for anxiety and depression and to assess parenting style. As expected, kids who had experienced corporal punishment were more likely to develop anxiety and depression.

“Our paper first replicates the well-known negative effect that corporal punishment has on a child’s wellbeing: we found that corporal punishment is associated with increased anxiety and depressive symptoms in adolescence. However, our study goes further to demonstrate that corporal punishment might impact brain activity and neurodevelopment,” said Burani.

That was reflected by larger neural response to error and a blunted response to reward in the adolescents who received physical punishments.

“Specifically,” Burani added, “our paper links corporal punishment to increased neural sensitivity to making errors and decreased neural sensitivity to receiving rewards in adolescence. In previous and ongoing work with Dr. Hajcak, we see that increased neural response to errors is associated with anxiety and risk for anxiety, whereas decreased neural response to rewards is related to depression and risk for depression. Corporal punishment, therefore, might alter specific neurodevelopmental pathways that increase risk for anxiety and depression by making children hypersensitive to their own mistakes and less reactive to rewards and other positive events in their environment.”

Cameron Carter, MD, Editor of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, said of the findings, “Using EEG, this study provides new insights into the mechanisms that may underlie the adverse effects of corporal punishment on mental health in children as well as the neural systems that may be affected.”

The work provides new clues as to the neural underpinnings of depression and anxiety and could help guide interventions for at-risk youth.

---

Notes for editors

The article is "Corporal Punishment Is Uniquely Associated with a Greater Neural Response to Errors and Blunted Neural Response to Rewards in Adolescence," by Kreshnik Burani, C.J. Brush, Chandler Spahr, George M. Slavich, Alexandria Meyer, and Greg Hajcak (https://doi.org/10.1016/j.bpsc.2022.09.004(opens in new tab/window)). It appears as an Article in Press in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging(opens in new tab/window), published by Elsevier.

Copies of this paper are available to credentialed journalists upon request; please contact Rhiannon Bugno at +1 254 522 9700 or [email protected](opens in new tab/window). Journalists wishing to interview the authors may contact Kreshnik Burani at [email protected](opens in new tab/window) or Greg Kajcak at [email protected](opens in new tab/window).

The authors’ affiliations and disclosures of financial and conflicts of interests are available in the article.

Cameron S. Carter, MD, is Professor of Psychiatry and Psychology and Director of the Center for Neuroscience at the University of California, Davis. His disclosures of financial and conflicts of interests are available here(opens in new tab/window).

About Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging(opens in new tab/window) is an official journal of the Society of Biological Psychiatry(opens in new tab/window), whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal focuses on studies using the tools and constructs of cognitive neuroscience, including the full range of non-invasive neuroimaging and human extra- and intracranial physiological recording methodologies. It publishes both basic and clinical studies, including those that incorporate genetic data, pharmacological challenges, and computational modeling approaches. The 2021 Journal Impact Factor (Clarivate, 2022) for Biological Psychiatry: Cognitive Neuroscience and Neuroimaging is 6.050.

About Elsevier

As a global leader in scientific information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies.

We have supported the work of our research and healthcare communities for more than 140 years. Our 9,500 employees around the world, including 2,500 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 2,900 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray’s Anatomy.

Together with the Elsevier Foundation(opens in new tab/window), we work in partnership with the communities we serve to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELX(opens in new tab/window), a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com.